Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives
Authors
Keywords
-
Journal
Nanomedicine
Volume 13, Issue 5, Pages 477-480
Publisher
Future Medicine Ltd
Online
2018-01-29
DOI
10.2217/nnm-2017-0383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world
- (2018) Minakshi Prasad et al. BIOMEDICINE & PHARMACOTHERAPY
- Cyclodextrins: structure, physicochemical properties and pharmaceutical applications
- (2018) Phatsawee Jansook et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections
- (2017) David Lembo et al. Expert Opinion on Drug Delivery
- Evolution of Cyclodextrin Nanosponges
- (2017) Fabrizio Caldera et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges
- (2016) Monica R P Rao et al. AAPS PHARMSCITECH
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses
- (2016) Martina Daga et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development
- (2016) Shankar Swaminathan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Complexation of a 1-Indanone Thiosemicarbazone with Hydroxypropyl-β-Cyclodextrin Enhances Its Activity Against a Hepatitis C Virus Surrogate Model
- (2015) Romina J. Glisoni et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Acute and Repeated Dose Toxicity Studies of Different β-Cyclodextrin-Based Nanosponge Formulations
- (2015) Pravin Shende et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Glutathione Bioresponsive Cyclodextrin Nanosponges
- (2015) Francesco Trotta et al. ChemPlusChem
- The application of nanosponges to cancer drug delivery
- (2014) Francesco Trotta et al. Expert Opinion on Drug Delivery
- Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
- (2013) Anroop B. Nair et al. DRUG DELIVERY
- Cyclodextrin-based nanosponges as drug carriers
- (2012) Francesco Trotta et al. Beilstein Journal of Organic Chemistry
- Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy
- (2012) David Lembo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges
- (2010) Satyen J. Torne et al. DRUG DELIVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started